In addition, these findings further support the hypothesis that the beneficial effects of propranolol in conditions such as PTSD, agitation, and schizophrenia may not be solely due to its β-adrenergic blockade, but also to its BChE inhibitory activity. The gene discussed is BCHE; the disease is schizophrenia.